Online citations, reference lists, and bibliographies.

Recent Developments In Drug Discovery Technologies

S. Grabley, R. Thiericke
Published 2000 · Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1038/372425a0
Positional cloning of the mouse obese gene and its human homologue
Y. Zhang (1994)
10.1038/384014a0
High-throughput screening for drug discovery.
J. Broach (1996)
10.1289/ehp.97105734
Evaluation of a recombinant yeast cell estrogen screening assay.
N. Coldham (1997)
10.1038/nbt0497-328
Combinatorial chemistry in drug discovery
Joseph C. Hogan (1997)
10.1073/pnas.91.13.5740
Sorting single molecules: application to diagnostics and evolutionary biotechnology.
M. Eigen (1994)
10.1021/np9604893
Natural products in drug discovery and development.
G. Cragg (1997)
10.1016/0958-1669(93)90037-W
Whole cell assays in screening for biologically active substances.
R. Hertzberg (1993)
10.1038/nbt0496-513
High throughput screening on a low budget
M. Palmer (1996)
10.1128/MCB.9.8.3517
Reconstitution of the vitamin D-responsive osteocalcin transcription unit in Saccharomyces cerevisiae.
D. McDonnell (1989)
10.1038/nbt1295-1474
The Yeast Tribrid System—Genetic Detection of trans-phosphorylated ITAM-SH2-Interactions
M. A. Osborne (1995)
10.1038/348166a0
Reduced levels of hsp90 compromise steroid receptor action in vivo
D. Picard (1990)
10.1038/nbt1096-1234
Moving beyond the genome projects
G. Friedrich (1996)
10.1126/science.2772657
Identification of the cystic fibrosis gene: chromosome walking and jumping
J. Rommens (1989)
10.1016/S0378-1119(96)00345-9
Activation of the human estrogen receptor by estrogenic and antiestrogenic compounds in Saccharomyces cerevisiae: a positive selection system.
S. Shiau (1995)
10.1016/0092-8674(93)90585-E
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
M. MacDonald (1993)
10.1016/S0167-7799(00)88916-7
Identifying small-molecule lead compounds: the screening approach to drug discovery.
P. Bevan (1995)
10.1016/0958-1669(93)90075-8
Development of improved cell-based assays and screens in Saccharomyces through the combination of molecular and classical genetics.
D. Kirsch (1993)
10.1016/S1387-2656(08)70029-2
The two-hybrid system in yeast: applications in biotechnology and basic research
T. Munder (1997)
10.1126/science.1354393
Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.
P. Liang (1992)
10.1126/science.2475911
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA
J. Riordan (1989)
10.1006/bbrc.1996.1836
Inhibition of progesterone receptor activity in yeast by synthetic chemicals.
D. Q. Tran (1996)
10.1038/384007a0
British ruling supports legal challenge to broad patents
D. Dickson (1996)
10.1016/1359-6446(96)89114-8
New perspectives in lead generation I: Discovery of biological targets
M. Ashton (1996)
10.1002/(SICI)1097-4644(19970801)66:2<184::AID-JCB6>3.0.CO;2-M
Expression of the vitamin D and the retinoid X receptors in Saccharomyces cerevisiae: Alternative in vivo models for ligand‐induced transactivation
Y. Berghöfer-Hochheimer (1997)
10.1126/science.2047873
Complementary DNA sequencing: expressed sequence tags and human genome project
M.D. Adams (1991)
10.1073/pnas.92.10.4701
LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones.
A. Kralli (1995)
10.1006/bbrc.1997.6417
Several synthetic chemicals inhibit progesterone receptor-mediated transactivation in yeast.
L. Jin (1997)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar